Literature DB >> 7806543

Thyroid hormone metabolism in a transthyretin-null mouse strain.

J A Palha1, V Episkopou, S Maeda, K Shimada, M E Gottesman, M J Saraiva.   

Abstract

Transthyretin (TTR) is the principal carrier of thyroid hormones in rodent plasma and the major protein synthesized by the choroid plexus. Mice lacking TTR generated by targeted disruption (Episkopou, V., Maeda, S., Nishiguchi, S., Shimada, K., Gaitanaris, G. A., Gottesman, M. E., and Robertson, E. J. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 2375-2379) had a 50% decrease in total thyroxine (T4) plasma levels but had normal free hormone levels as compared to wild-type mice. In the mutant serum there was increased T4 binding to thyroxine-binding globulin. Thyroxine-binding globulin mRNA levels were the same in mutant and wild-type animals. Wild-type serum depleted of TTR also presented increased T4 binding to thyroxine-binding globulin, suggesting that TTR competes with thyroxine-binding globulin for T4 binding. Total and free triiodothyronine and thyrotoropin-stimulating hormone levels were not affected by the absence of TTR. Liver deiodinase-I activity, mRNA levels, and brain deiodinase-II activity were normal in the mutant mice, suggesting that the absence of TTR does not affect tissue thyroid hormone content. The low T4 levels found in the mutant mice sera cannot be accounted for by increased glucuronidation because the liver activity of UDP-glucuronosyltransferase was not affected in the TTR-deficient mice. We concluded that transthyretin-deficient mice are euthyroid in the absence of the major plasma T4 carrier. We ascribed this to the normal free hormone levels in the serum of the mutant mice. Our data, therefore, strongly supported the free hormone hypothesis for thyroxine uptake (Mendel, C. M. (1989) Endocr. Rev. 10, 232-274).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7806543

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Action of thyroid hormone in brain.

Authors:  J Bernal
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

2.  Inhibition by lead of production and secretion of transthyretin in the choroid plexus: its relation to thyroxine transport at blood-CSF barrier.

Authors:  W Zheng; W S Blaner; Q Zhao
Journal:  Toxicol Appl Pharmacol       Date:  1999-02-15       Impact factor: 4.219

Review 3.  The menace of endocrine disruptors on thyroid hormone physiology and their impact on intrauterine development.

Authors:  George Mastorakos; Eftychia I Karoutsou; Maria Mizamtsidi; George Creatsas
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

4.  An association study between the transthyretin (TTR) gene and mental retardation.

Authors:  Jun Li; Jian-Jun Gao; Fu-Chang Zhang; Qing-He Xing; Fang-Li Dang; Xiao-Cai Gao; Shi-Wei Duan; Zi-Jian Zheng; Xue-Qing Qian; Wei Qin; Xing-Wang Li; Yan-Feng Han; Jing Li; Guo-Yin Feng; D St Clair; Lin He
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-12-19       Impact factor: 5.270

5.  Inhibiting transthyretin conformational changes that lead to amyloid fibril formation.

Authors:  S A Peterson; T Klabunde; H A Lashuel; H Purkey; J C Sacchettini; J W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

Review 6.  A review of species differences in the control of, and response to, chemical-induced thyroid hormone perturbations leading to thyroid cancer.

Authors:  John R Foster; Helen Tinwell; Stephanie Melching-Kollmuss
Journal:  Arch Toxicol       Date:  2021-01-05       Impact factor: 5.153

7.  Delayed development of specific thyroid hormone-regulated events in transthyretin null mice.

Authors:  Julie A Monk; Natalie A Sims; Katarzyna M Dziegielewska; Roy E Weiss; Robert G Ramsay; Samantha J Richardson
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-23       Impact factor: 4.310

8.  Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice.

Authors:  Nimesh Mody; Timothy E Graham; Yuki Tsuji; Qin Yang; Barbara B Kahn
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-02-19       Impact factor: 4.310

9.  Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicity.

Authors:  Joel N Buxbaum; Zhengyi Ye; Natàlia Reixach; Linsey Friske; Coree Levy; Pritam Das; Todd Golde; Eliezer Masliah; Amanda R Roberts; Tamas Bartfai
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-12       Impact factor: 11.205

10.  The serum protein transthyretin as a platform for dimerization and tetramerization of antibodies and Fab fragments to enable target clustering.

Authors:  Kenneth W Walker; Ian N Foltz; Tina Wang; Hossein Salimi-Moosavi; Julie M Bailis; Fei Lee; Phillip An; Stephen Smith; Richele Bruno; Zhulun Wang
Journal:  J Biol Chem       Date:  2020-06-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.